MedTrace Logo

Persistant Organics Pollutants in Breast Cancer.

NCT03788187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-12-27

No results posted yet for this study

Summary

Persistant Organics Pollutants (POP) accumulate in the adipose tissue (AT) and could modulate tumor progression as part of the microenvironment. The investigators tested the hypothesis that POPs exposure may be associated with breast cancer metastasis analyzing the concentrations of 46 POPs in both adipose tissue and serum samples from breast tumor patients (benign, malignant with and without lymph node metastasis)

Conditions

  • Breast Cancer
  • Persistant Organic Pollutants
  • Lymph Node Metastases

Interventions

OTHER

Blood test sample

OTHER

Peritumoral adipose tissue sample

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • ONIRIS

    collaborator INDUSTRY

  • European Georges Pompidou Hospital

    lead OTHER

Principal Investigators

  • Anne-Sophie BATS, MD, PhD · European Hospital Georges Pompidou

Study Design

Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2013-12-27
Completion
2017-09-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03788187 on ClinicalTrials.gov